Status:
RECRUITING
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Lead Sponsor:
Ain Shams University
Conditions:
Leukaemia (Acute)
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
2-18 years
Phase:
PHASE4
Brief Summary
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
Detailed Description
Children and adolescent with acute lymphoblastic leukemia (ALL) can exhibit a wide spectrum of hepatotoxicity ranging from asymptomatic to clinically significant during induction chemotherapy. Unmonit...
Eligibility Criteria
Inclusion
- Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams
Exclusion
- Known chronic liver disease.
Key Trial Info
Start Date :
November 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06918054
Start Date
November 17 2023
End Date
August 1 2025
Last Update
April 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11566
2
Faculty of Medicine Ain Shams Research Institute- Clinical Research Center (MASRI-CRC)
Cairo, Egypt, 11566